April 6 (Reuters) -
* Allergan (NYSE:AGN_pa) CEO Saunders says committed to double-digit
revenue growth in branded products
* Allergan CEO says everything is on the table including
share buybacks and returning capital to shareholders
* Allergan CEO says Valeant's B&L is different enough than
Allergan's, but unclear if it is a growth business that would be
good M&A target
* Allergan CEO also says that Bausch & Lomb is not for sale